Do you want to read an article? Please log in or register.
Recent progress in therapeutic antibodies for cancer immunotherapy
Immunotherapy
Related content
Immunotherapy
Novel immunotherapy strategies for hepatobiliary cancers
Immunotherapy.
DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ
doi: 10.2217/imt-2018-0024.
ImmunotherapyT Cells
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers
Clin Sci (Lond).
Inthagard J, Edwards J, Roseweir AK
doi: 10.1042/CS20181003.
RECOMMENDED
Immunotherapy
Development of a novel class of interleukin-2 immunotherapies for metastatic cancer
doi: smw.2019.14697.
ImmunotherapyImmunomodulation
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
★ 3
Recommended by
Alexander Meisel, Faculty Member
J Immunother Cancer
Rodrigues Mantuano N, Natoli M, Zippelius A, Läubli H
doi: 10.1136/jitc-2020-001222
Immunotherapy
Immunotherapy in Gastrointestinal Cancers
Biomed Res Int.
Procaccio L, Schirripa M, Fassan M, Vecchione L, Bergamo F, Prete AA, Intini R, Manai C, Dadduzio V, Boscolo A, Zagonel V, Lonardi S
doi: 10.1155/2017/4346576.
Melanoma and Skin CancerImmunotherapy
Identification of essential genes for cancer immunotherapy
Nature.
Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP
doi: 10.1038/nature23477.
Melanoma and Skin Cancer
Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis
Int Immunopharmacol.
Caisová V, Uher O, Nedbalová P, Jochmanová I, Kvardová K, Masáková K, Krejčová G, Paďouková L, Chmelař J, Kopecký J, Ženka J
doi: 10.1016/
Immunotherapy
Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
Front Oncol.
Le Bourgeois T, Strauss L, Aksoylar HI, Daneshmandi S, Seth P, Patsoukis N, Boussiotis VA
doi: 10.3389/fonc.2018.00237.
T Cells
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
Semin Cancer Biol.
Kumar P, Saini S, Prabhakar BS
doi: 10.1016/j.semcancer.